Personal information

Activities

Employment (3)

Massachusetts General Hospital: Boston, Massachusetts, US

Physician (Cardiology)
Employment
Source: Self-asserted source
James Januzzi

Harvard Medical School: Boston, MA, US

Employment
Source: Self-asserted source
James Januzzi

Baim Institute for Clinical Research: Boston, Massachusetts, US

Employment
Source: Self-asserted source
James Januzzi

Education and qualifications (2)

New York Medical College: Valhalla, NY, US

Education
Source: Self-asserted source
James Januzzi

College of the Holy Cross: Worcester, MA, US

Education
Source: Self-asserted source
James Januzzi

Professional activities (5)

Heart Failure Society of America: Bethesda, Maryland, US

Member
Membership
Source: Self-asserted source
James Januzzi

European Society of Cardiology: Paris, FR

Fellow
Membership
Source: Self-asserted source
James Januzzi

European Society of Cardiology: Antibes, FR

(Heart Failure Association)
Membership
Source: Self-asserted source
James Januzzi

American Heart Association: Dallas, Texas, US

Member
Membership
Source: Self-asserted source
James Januzzi

American College of Cardiology: Washington, DC, US

Trustee
Membership
Source: Self-asserted source
James Januzzi

Works (50 of 54)

Items per page:
Page 1 of 2

Multiple Biomarkers to Predict Major Adverse Cardiovascular Events in Patients With Coronary Chronic Total Occlusions

The American Journal of Cardiology
2025-05 | Journal article
Contributors: Srikanth Adusumalli; Cian P. McCarthy; Craig A. Magaret; Rhonda F. Rhyne; Farouc A. Jaffer; James L. Januzzi
Source: check_circle
Crossref

Effects of Sodium-Glucose Cotransporter-2 Inhibitors on Kidney Outcomes across Baseline Cardiovascular-Kidney-Metabolic Conditions

Journal of the American Society of Nephrology
2025-02 | Journal article
Contributors: Tariq Jamal Siddiqi; David Cherney; Hasan Fareed Siddiqui; Tazeen H. Jafar; James L. Januzzi; Muhammad Shahzeb Khan; Adeera Levin; Nikolaus Marx; Janani Rangaswami; Jeffrey Testani et al.
Source: check_circle
Crossref

High-Sensitivity Cardiac Troponin Assays: From Implementation to Resource Utilization and Cost Effectiveness

The Journal of Applied Laboratory Medicine
2025-02-05 | Journal article
Contributors: Hong-Kee Lee; Cian P McCarthy; Allan S Jaffe; Richard Body; Ahmed Alotaibi; Yader Sandoval; James L Januzzi, Jr.
Source: check_circle
Crossref

Cardiac biomarkers and effects of aficamten in obstructive hypertrophic cardiomyopathy: the SEQUOIA-HCM trial

2024-08-21 | Other
Contributors: James L Januzzi; Caroline Coats; Ahmad Masri; Roberto Barriales-Villa; Theodore P. Abraham; D. Marshall Brinkley; Brian L. Claggett; Albert Hagege; Sheila M. Hegde; Carolyn Y. Ho et al.
Source: check_circle
Crossref

Lipoprotein(a), Oxidized Phospholipids, and Progression to Symptomatic Heart Failure: The CASABLANCA Study

Journal of the American Heart Association
2024-06-18 | Journal article
Contributors: James L. Januzzi, Jr; Roland R. J. van Kimmenade; Yuxi Liu; Xingdi Hu; Auris Browne; Jorge Plutzky; Sotirios Tsimikas; Ron Blankstein; Pradeep Natarajan
Source: check_circle
Crossref

Data from Statins Do Not Significantly Affect Oxidative Nitrosative Stress Biomarkers in the PREVENT Randomized Clinical Trial

2024-06-03 | Preprint
Contributors: Igor Makhlin; Biniyam G. Demissei; Ralph D'Agostino; W. Greg Hundley; Camelia Baleanu-Gogonea; Nicholas S. Wilcox; Anna Chen; Amanda M. Smith; Nathaniel Sean O'Connell; James L. Januzzi et al.
Source: check_circle
Crossref

Data from Statins Do Not Significantly Affect Oxidative Nitrosative Stress Biomarkers in the PREVENT Randomized Clinical Trial

2024-06-03 | Preprint
Contributors: Igor Makhlin; Biniyam G. Demissei; Ralph D'Agostino; W. Greg Hundley; Camelia Baleanu-Gogonea; Nicholas S. Wilcox; Anna Chen; Amanda M. Smith; Nathaniel Sean O'Connell; James L. Januzzi et al.
Source: check_circle
Crossref

Statins Do Not Significantly Affect Oxidative Nitrosative Stress Biomarkers in the PREVENT Randomized Clinical Trial

Clinical Cancer Research
2024-06-03 | Journal article
Contributors: Igor Makhlin; Biniyam G. Demissei; Ralph D'Agostino; W. Greg Hundley; Camelia Baleanu-Gogonea; Nicholas S. Wilcox; Anna Chen; Amanda M. Smith; Nathaniel Sean O'Connell; James L. Januzzi et al.
Source: check_circle
Crossref

Supplemental Table S1 from Statins Do Not Significantly Affect Oxidative Nitrosative Stress Biomarkers in the PREVENT Randomized Clinical Trial

2024-06-03 | Preprint
Contributors: Igor Makhlin; Biniyam G. Demissei; Ralph D'Agostino; W. Greg Hundley; Camelia Baleanu-Gogonea; Nicholas S. Wilcox; Anna Chen; Amanda M. Smith; Nathaniel Sean O'Connell; James L. Januzzi et al.
Source: check_circle
Crossref

Supplemental Table S1 from Statins Do Not Significantly Affect Oxidative Nitrosative Stress Biomarkers in the PREVENT Randomized Clinical Trial

2024-06-03 | Preprint
Contributors: Igor Makhlin; Biniyam G. Demissei; Ralph D'Agostino; W. Greg Hundley; Camelia Baleanu-Gogonea; Nicholas S. Wilcox; Anna Chen; Amanda M. Smith; Nathaniel Sean O'Connell; James L. Januzzi et al.
Source: check_circle
Crossref

Supplemental Table S2 from Statins Do Not Significantly Affect Oxidative Nitrosative Stress Biomarkers in the PREVENT Randomized Clinical Trial

2024-06-03 | Preprint
Contributors: Igor Makhlin; Biniyam G. Demissei; Ralph D'Agostino; W. Greg Hundley; Camelia Baleanu-Gogonea; Nicholas S. Wilcox; Anna Chen; Amanda M. Smith; Nathaniel Sean O'Connell; James L. Januzzi et al.
Source: check_circle
Crossref

Supplemental Table S2 from Statins Do Not Significantly Affect Oxidative Nitrosative Stress Biomarkers in the PREVENT Randomized Clinical Trial

2024-06-03 | Preprint
Contributors: Igor Makhlin; Biniyam G. Demissei; Ralph D'Agostino; W. Greg Hundley; Camelia Baleanu-Gogonea; Nicholas S. Wilcox; Anna Chen; Amanda M. Smith; Nathaniel Sean O'Connell; James L. Januzzi et al.
Source: check_circle
Crossref

Emerging Biomarkers in the Laboratory and in Practice: A Novel Approach to Diagnosing Heart Failure in Diabetes

Journal of Diabetes Science and Technology
2024-05 | Journal article
Contributors: Rachel E. Aaron; Tiffany Tian; G. Alexander Fleming; David B. Sacks; James L. Januzzi, Jr.; MD FACC; Rodica Pop-Busui; Ibrahim A. Hashim; Alan H. B. Wu; Ambarish Pandey et al.
Source: check_circle
Crossref

Vascular endothelial growth factors and risk of cardio-renal events: Results from the CREDENCE trial

American Heart Journal
2024-05 | Journal article
Contributors: James L. Januzzi, Jr.; Yuxi Liu; Naveed Sattar; Yshai Yavin; Carol A. Pollock; Javed Butler; Meg Jardine; Hiddo J.L. Heerspink; Serge Masson; Matthew Breyer et al.
Source: check_circle
Crossref

Classification Algorithm to Distinguish Between Type 1 and Type 2 Myocardial Infarction in Administrative Claims Data

Circulation: Cardiovascular Quality and Outcomes
2024-02 | Journal article
Contributors: Jason H. Wasfy; Mary Price; Sharon-Lise T. Normand; James L. Januzzi, Jr; Cian P. McCarthy; John Hsu
Source: check_circle
Crossref

Agreement among high-sensitivity cardiac troponin assays and non-invasive testing, clinical outcomes, and quality-of-care outcomes based on the 2020 European Society of Cardiology Guidelines

European Heart Journal: Acute Cardiovascular Care
2024-02-09 | Journal article
Contributors: Júlia Karády; Thomas Mayrhofer; James L Januzzi; James E Udelson; Jerome L Fleg; Bela Merkely; Michael T Lu; William F Peacock; John T Nagurney; Wolfgang Koenig et al.
Source: check_circle
Crossref

Race-Free Creatinine-Based Estimation of GFR and Projection of CKD to 2060 in the United States

Clinical Journal of the American Society of Nephrology
2023-11 | Journal article
Contributors: Reza Mohebi; Josef Coresh; Deidra C. Crews; Michelle M. Estrella; Andrew S. Levey; Yuxi Liu; Kunihiro Matsushita; Michael G. Shlipak; James L. Januzzi
Source: check_circle
Crossref

Circulating Cardiovascular Biomarkers in Cancer Therapeutics‐Related Cardiotoxicity: Review of Critical Challenges, Solutions, and Future Directions

Journal of the American Heart Association
2023-11-07 | Journal article
Contributors: Gillian Murtagh; James L. Januzzi; Marielle Scherrer‐Crosbie; Tomas G. Neilan; Susan Dent; Jennifer E. Ho; Vinesh Appadurai; Ray McDermott; Nausheen Akhter
Source: check_circle
Crossref

Cardiorenal Biomarkers, Canagliflozin, and Outcomes in Diabetic Kidney Disease: The CREDENCE Trial

Circulation
2023-08-22 | Journal article
Contributors: James L. Januzzi; Reza Mohebi; Yuxi Liu; Naveed Sattar; Hiddo J.L. Heerspink; Eshetu Tefera; Muthiah Vaduganathan; Javed Butler; Yshai Yavin; Jingwei Li et al.
Source: check_circle
Crossref

Presence of Peripheral Artery Disease Is Associated With Increased Risk of Heart Failure Events: Insights From EMPEROR-Pooled

Arteriosclerosis, Thrombosis, and Vascular Biology
2023-07 | Journal article
Contributors: Subodh Verma; Nitish K. Dhingra; Marc P. Bonaca; Javed Butler; Stefan D. Anker; João Pedro Ferreira; Gerasimos Filippatos; James L. Januzzi; Carolyn S.P. Lam; Naveed Sattar et al.
Source: check_circle
Crossref

Racial Differences in Quality of Life in Patients With Heart Failure Treated With Sodium–Glucose Cotransporter 2 Inhibitors: A Patient-Level Meta-Analysis of the CHIEF-HF, DEFINE-HF, and PRESERVED-HF Trials

Circulation
2023-07-18 | Journal article
Contributors: Kashvi Gupta; John A. Spertus; Mary Birmingham; Kensey L. Gosch; Mansoor Husain; Dalane W. Kitzman; Bertram Pitt; Sanjiv J. Shah; James L. Januzzi; Ildiko Lingvay et al.
Source: check_circle
Crossref

Mechanistic Efficacy of Sacubitril/Valsartan in Ischemic Versus Nonischemic Heart Failure

Journal of the American Heart Association
2023-04-18 | Journal article
Contributors: Reza Mohebi; Yuxi Liu; G. Michael Felker; Jonathan H. Ward; Ileana L. Piña; Javed Butler; Scott D. Solomon; James L. Januzzi
Source: check_circle
Crossref

Pleiotropic Effects of Sodium-Glucose Cotransporter-2 Inhibitors in Cardiovascular Disease and Chronic Kidney Disease

Journal of Clinical Medicine
2023-04-12 | Journal article
Contributors: Anjay Rastogi; James Januzzi, Jr.
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

A Composite Score Summarizing Use and Dosing of Evidence-Based Medical Therapies in Heart Failure: A Nationwide Cohort Study

Circulation: Heart Failure
2023-02 | Journal article
Contributors: Niklas Dyrby Johansen; Muthiah Vaduganathan; Deewa Zahir; Mona Fiuzat; Ersilia M. DeFilippis; James L. Januzzi; Javed Butler; Christopher M. O’Connor; William T. Abraham; Mitchell A. Psotka et al.
Source: check_circle
Crossref

Empagliflozin in Black Versus White Patients With Heart Failure: Analysis of EMPEROR-Pooled

Circulation
2023-01-03 | Journal article
Contributors: Subodh Verma; Nitish K. Dhingra; Javed Butler; Stefan D. Anker; João Pedro Ferreira; Gerasimos Filippatos; James L. Januzzi; Carolyn S.P. Lam; Naveed Sattar; Egon Pfarr et al.
Source: check_circle
Crossref

Impact of Empagliflozin in Heart Failure With Reduced Ejection Fraction in Patients With Ischemic Versus Nonischemic Cause

Journal of the American Heart Association
2023-01-03 | Journal article
Contributors: Muhammad Shahzeb Khan; Javed Butler; Stefan D. Anker; Gerasimos Filippatos; João Pedro Ferreira; Stuart J. Pocock; James L. Januzzi; Ileana L. Piña; Michael Böhm; Piotr Ponikowski et al.
Source: check_circle
Crossref

Correction: Retrospective analysis of arterial occlusive events in the PACE trial by an independent adjudication committee

Journal of Hematology & Oncology
2022-12 | Journal article
Contributors: James L. Januzzi; Joseph M. Garasic; Scott E. Kasner; Vickie McDonald; Mark C. Petrie; Jonathan Seltzer; Michael Mauro; Kevin Croce; Ellin Berman; Michael Deininger et al.
Source: check_circle
Crossref

Heart Failure Duration and Mechanistic Efficacy of Sacubitril/Valsartan in Heart Failure With Reduced Ejection Fraction

Journal of Cardiac Failure
2022-12 | Journal article
Contributors: REZA Mohebi; YUXI LIU; G. MICHAEL FELKER; MARGARET F. PRESCOTT; JONATHAN H. WARD; ILEANA L. PIÑA; JAVED BUTLER; SCOTT D. SOLOMON; JAMES L. JANUZZI
Source: check_circle
Crossref

Retrospective analysis of arterial occlusive events in the PACE trial by an independent adjudication committee

Journal of Hematology & Oncology
2022-12 | Journal article
Contributors: James L. Januzzi; Joseph M. Garasic; Scott E. Kasner; Vickie McDonald; Mark C. Petrie; Jonathan Seltzer; Michael Mauro; Kevin Croce; Ellin Berman; Michael Deininger et al.
Source: check_circle
Crossref

Effect of empagliflozin on circulating proteomics in heart failure: mechanistic insights into the EMPEROR programme

European Heart Journal
2022-12-21 | Journal article
Contributors: Faiez Zannad; João Pedro Ferreira; Javed Butler; Gerasimos Filippatos; James L Januzzi; Mikhail Sumin; Matthias Zwick; Maral Saadati; Stuart J Pocock; Naveed Sattar et al.
Source: check_circle
Crossref

Association Between Sacubitril/Valsartan Initiation and Mitral Regurgitation Severity in Heart Failure With Reduced Ejection Fraction: The PROVE-HF Study

Circulation
2022-11-22 | Journal article
Contributors: James L. Januzzi; Alaa Mabrouk Salem Omar; Yuxi Liu; Sean Murphy; Javed Butler; G. Michael Felker; Iliana L. Piña; Jonathan Ward; Scott Solomon; Johanna Contreras
Source: check_circle
Crossref

Endovascular Baroreflex Amplification With the MobiusHD Device in Patients With Heart Failure and Reduced Ejection Fraction: Interim Analysis of the First-in-Human Results

Structural Heart
2022-10 | Journal article
Contributors: Kerstin Piayda; Kolja Sievert; Horst Sievert; Tamaz Shaburishvili; Irakli Gogorishvili; Martin Rothman; James L. Januzzi, Jr; JoAnn Lindenfeld; Gregg W. Stone
Source: check_circle
Crossref

Inflammatory biomarkers and risk of cardiovascular events in patients undergoing coronary angiography

American Heart Journal
2022-10 | Journal article
Contributors: Reza Mohebi; Cian P. McCarthy; Hanna K. Gaggin; Roland R.J. van Kimmenade; James L. Januzzi
Source: check_circle
Crossref

Relation of High-Sensitivity Cardiac Troponin I and Obstructive Coronary Artery Disease in Patients Without Acute Myocardial Infarction

The American Journal of Cardiology
2022-06 | Journal article
Contributors: Reza Mohebi; Laurel Jackson; Cian P. McCarthy; Gillian Murtagh; Sean P. Murphy; Andrew Abboud; Hannah Miksenas; Hanna K. Gaggin; James L. Januzzi, Jr
Source: check_circle
Crossref

Performance of a protein biomarker panel for prediction of cardiovascular events in patients with diabetes mellitus

European Journal of Preventive Cardiology
2022-05-27 | Journal article
Contributors: Reza Mohebi; Cian P McCarthy; Craig A Magaret; Grady Barnes; Rhonda F Rhyne; Celine Peters; Hanna K Gaggin; James L Januzzi, Jr
Source: check_circle
Crossref

A Biomarker‐Enhanced Model for Prediction of Acute Kidney Injury and Cardiovascular Risk Following Angiographic Procedures: CASABLANCA AKI Prediction Substudy

Journal of the American Heart Association
2022-05-17 | Journal article
Contributors: Reza Mohebi; Roland van Kimmenade; Cian McCarthy; Hanna Gaggin; Roxana Mehran; George Dangas; James L. Januzzi, Jr
Source: check_circle
Crossref

The SGLT2 inhibitor canagliflozin in heart failure: the CHIEF-HF remote, patient-centered randomized trial

Nature Medicine
2022-04 | Journal article
Contributors: John A. Spertus; Mary C. Birmingham; Michael Nassif; C. V. Damaraju; Antonio Abbate; Javed Butler; David E. Lanfear; Ildiko Lingvay; Mikhail N. Kosiborod; James L. Januzzi
Source: check_circle
Crossref

Empagliflozin, Health Status, and Quality of Life in Patients With Heart Failure and Preserved Ejection Fraction: The EMPEROR-Preserved Trial

Circulation
2022-01-18 | Journal article
Contributors: Javed Butler; Gerasimos Filippatos; Tariq Jamal Siddiqi; Martina Brueckmann; Michael Böhm; Vijay K. Chopra; João Pedro Ferreira; James L. Januzzi; Sanjay Kaul; Ileana L. Piña et al.
Source: check_circle
Crossref

Novel biomarker-driven prognostic models to predict morbidity and mortality in chronic heart failure: the EMPEROR-Reduced trial

European Heart Journal
2021-11-14 | Journal article
Contributors: Stuart J Pocock; João Pedro Ferreira; John Gregson; Stefan D Anker; Javed Butler; Gerasimos Filippatos; Nicholas D Gollop; Tomoko Iwata; Martina Brueckmann; James L Januzzi, Jr et al.
Source: check_circle
Crossref

Asymptomatic Diabetic Cardiomyopathy: an Underrecognized Entity in Type 2 Diabetes

Current Diabetes Reports
2021-10 | Journal article
Contributors: Ana Maria Stanton; Muthiah Vaduganathan; Lee-Shing Chang; Alexander Turchin; James L. Januzzi, Jr; Vanita R. Aroda
Source: check_circle
Crossref

The Intersection of Type 2 Myocardial Infarction and Heart Failure

Journal of the American Heart Association
2021-09-07 | Journal article
Contributors: Cian P. McCarthy; Maeve Jones‐O’Connor; David S. Olshan; Sean Murphy; Saad Rehman; Joshua A. Cohen; Jinghan Cui; Avinainder Singh; Muthiah Vaduganathan; James L. Januzzi, Jr et al.
Source: check_circle
Crossref

Causes of Cardiovascular Hospitalization and Death in Patients With Transthyretin Amyloid Cardiomyopathy (from the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial [ATTR-ACT])

The American Journal of Cardiology
2021-06 | Journal article
Contributors: Alan B. Miller; James L. Januzzi; Blair J. O'Neill; Balarama Gundapaneni; Terrell A. Patterson; Marla B. Sultan; José López-Sendón
Source: check_circle
Crossref

Probabilistic Readjudication of Heart Failure Hospitalization Events in the PARAGON-HF Study

Circulation
2021-06-08 | Journal article
Contributors: G. Michael Felker; Javed Butler; James L. Januzzi, Jr; Akshay S. Desai; John J.V. McMurray; Scott D. Solomon
Source: check_circle
Crossref

Economic Evaluation of an N-terminal Pro B-type Natriuretic Peptide-Supported Diagnostic Strategy Among Dyspneic Patients Suspected of Acute Heart Failure in the Emergency Department

The American Journal of Cardiology
2021-05 | Journal article
Contributors: Uwe Siebert; Sandra Milev; Denise Zou; Michal Litkiewicz; Hannah K. Gaggin; Linda Tirapelle; Serge Masson; James L. Januzzi
Source: check_circle
Crossref

Empagliflozin and health-related quality of life outcomes in patients with heart failure with reduced ejection fraction: the EMPEROR-Reduced trial

European Heart Journal
2021-03-31 | Journal article
Contributors: Javed Butler; Stefan D Anker; Gerasimos Filippatos; Muhammad Shahzeb Khan; João Pedro Ferreira; Stuart J Pocock; Nadia Giannetti; James L Januzzi; Ileana L Piña; Carolyn S P Lam et al.
Source: check_circle
Crossref

Cardiologist Evaluation of Patients With Type 2 Myocardial Infarction

Circulation: Cardiovascular Quality and Outcomes
2021-01 | Journal article
Contributors: Cian P. McCarthy; David S. Olshan; Saad Rehman; Maeve Jones-O’Connor; Sean Murphy; Joshua A. Cohen; Avinainder Singh; Muthiah Vaduganathan; James L. Januzzi, Jr; Jason H. Wasfy
Source: check_circle
Crossref

Insulin-Like Growth Factor Binding Protein 7 Predicts Renal and Cardiovascular Outcomes in the Canagliflozin Cardiovascular Assessment Study

Diabetes Care
2021-01-01 | Journal article
Contributors: James L. Januzzi, Jr.; Javed Butler; Naveed Sattar; Jialin Xu; Wayne Shaw; Norman Rosenthal; Michael Pfeifer; Kenneth W. Mahaffey; Bruce Neal; Michael K. Hansen
Source: check_circle
Crossref

Increasingly Sensitive Troponin Assays: Is Perfect the Enemy of Good?

Journal of the American Heart Association
2020-12 | Journal article
Contributors: Cian P. McCarthy; James L. Januzzi, Jr
Source: check_circle
Crossref

Psychiatric and Psychological Interventions for Depression in Patients With Heart Disease: A Scoping Review

Journal of the American Heart Association
2020-11-17 | Journal article
Contributors: Juliana Zambrano; Christopher M. Celano; James L. Januzzi; Christina N. Massey; Wei‐Jean Chung; Rachel A. Millstein; Jeff C. Huffman
Source: check_circle
Crossref

Racial Differences in Serial NT-proBNP Levels in Heart Failure Management

Circulation
2020-09-08 | Journal article
Contributors: Vibhu Parcha; Nirav Patel; Rajat Kalra; Garima Arora; James L. Januzzi, Jr; G. Michael Felker; Thomas J. Wang; Pankaj Arora
Source: check_circle
Crossref
Items per page:
Page 1 of 2

Peer review (3 reviews for 3 publications/grants)

Review activity for Nature cardiovascular research. (1)
Review activity for Nature medicine. (1)
Review activity for The lancet. (1)